These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8658985)

  • 21. Carcinoma of areola and nipple of the breast: Paget's disease versus carcinoma in situ.
    Underwood LJ; Green WS
    Arch Dermatol; 1965 Apr; 91(4):407-8. PubMed ID: 9626095
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation between type and grade of ductal carcinoma in situ and concomitant invasive ductal carcinoma of the breast.
    Rudnicka L; Stachura J
    Pol J Pathol; 2000; 51(3):137-43. PubMed ID: 11247396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-stratified incidence of unsuspected mammary carcinoma in women with fibroadenoma.
    Ricci A; Kourea HP; Wortyla S
    Conn Med; 1996 Oct; 60(10):587-90. PubMed ID: 8952131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association of diffuse breast cancer and malignant lymphoma of the colon].
    Simonov NN; Leonenkov VV; Riazankina AA; Kovalëv VK; Makeeva TK; El'tsin SS
    Vestn Khir Im I I Grek; 1997; 156(6):63-4. PubMed ID: 9505392
    [No Abstract]   [Full Text] [Related]  

  • 25. Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas.
    Tuck AB; O'Malley FP; Singhal H; Tonkin KS; Harris JF; Bautista D; Chambers AF
    Arch Pathol Lab Med; 1997 Jun; 121(6):578-84. PubMed ID: 9199622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiosarcoma of the breast occurring soon after lumpectomy and breast irradiation for infiltrating ductal carcinoma: a case report.
    Deutsch M; Safyan E
    Am J Clin Oncol; 2003 Oct; 26(5):471-2. PubMed ID: 14528072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lobular carcinoma-in-situ in a fibroadenoma. Observations on a case].
    Pizzoli G; Favret M
    Arch De Vecchi Anat Patol; 1980; 64(1):117-22. PubMed ID: 7294856
    [No Abstract]   [Full Text] [Related]  

  • 28. [Surgical therapy strategies in carcinoma in situ of the breast].
    Mosny DS
    Praxis (Bern 1994); 1998 Apr; 87(15):516-9. PubMed ID: 9608247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of ductal carcinoma in situ.
    Mokbel K; Wells C; Carpenter R
    N Engl J Med; 1999 Sep; 341(13):998-9; author reply 1000. PubMed ID: 10498500
    [No Abstract]   [Full Text] [Related]  

  • 30. Synchronous presentation of breast carcinoma with plasmacytoid cytomorphology and multiple myeloma.
    Khalbuss WE; Fischer G; Ahmad M; Villas B
    Breast J; 2006; 12(2):165-7. PubMed ID: 16509843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet?
    Silverstein MJ; Craig PH; Lagios MD; Waisman JK; Lewinsky BS; Colburn WJ; Poller DN
    Cancer; 1996 Sep; 78(5):1138-40. PubMed ID: 8780555
    [No Abstract]   [Full Text] [Related]  

  • 32. Contralateral breast cancer: factors associated with stage and size at presentation.
    Mertens WC; Hilbert V; Makari-Judson G
    Breast J; 2004; 10(4):304-12. PubMed ID: 15239788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Developmental trends in breast pathology].
    Böcker W
    Pathologe; 1997 Jan; 18(1):1-2. PubMed ID: 9157397
    [No Abstract]   [Full Text] [Related]  

  • 35. Synchronous bilateral breast cancer with different biological profile and estrogen-progesterone receptor status.
    Filippakis GM; Georgiadou D; Pararas N; Lanitis S; Zografos G
    Breast J; 2008; 14(2):209-10. PubMed ID: 18298610
    [No Abstract]   [Full Text] [Related]  

  • 36. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?
    Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL
    Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bilateral breast carcinoma. 12 years' experience].
    Maculotti L; Gandini F; Pradella P
    Minerva Chir; 1996; 51(1-2):33-7. PubMed ID: 8677043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More on breast cancer guidelines.
    Ramsay WR
    CMAJ; 1998 Jun; 158(11):1427, 1429; author reply 1429-30. PubMed ID: 9629099
    [No Abstract]   [Full Text] [Related]  

  • 39. No increased Ki67 expression in ductal carcinoma in situ associated with invasive breast cancer.
    Hoque A; Menter DG; Sahin AA; Sneige N; Lippman SM
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):153-4. PubMed ID: 11219775
    [No Abstract]   [Full Text] [Related]  

  • 40. More on breast cancer guidelines.
    Rieckenberg M
    CMAJ; 1998 Jun; 158(11):1426-7; author reply 1429-30. PubMed ID: 9629098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.